Trial intelligence / Profile preview

SBG + Standard Therapy in Advanced Breast Cancer

NCT00533364Phase 2Completed

Sponsor
Biotec Pharmacon ASA
Start
Jan 2007
Primary completion
Aug 2009
Modality
Polysaccharide, Biologic
Countries
1
01

Overview

A Phase 2 trial of Soluble Beta-Glucan in breast cancer, sponsored by Biotec Pharmacon ASA. Started Jan 2007; status: completed.

02

Drugs

Soluble Beta-Glucan
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00533364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00533364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call